IRIS
MOLINELLI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.421
EU - Europa 1.437
AS - Asia 197
SA - Sud America 9
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 5.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.409
IT - Italia 402
IE - Irlanda 260
SE - Svezia 230
UA - Ucraina 166
DE - Germania 95
FR - Francia 78
SG - Singapore 75
GB - Regno Unito 68
DK - Danimarca 43
IN - India 33
TR - Turchia 32
FI - Finlandia 31
CN - Cina 21
KR - Corea 21
BE - Belgio 15
NL - Olanda 15
RU - Federazione Russa 13
CA - Canada 9
JP - Giappone 9
BR - Brasile 7
GR - Grecia 7
TH - Thailandia 5
AT - Austria 3
CI - Costa d'Avorio 3
EU - Europa 3
MX - Messico 3
AU - Australia 2
CZ - Repubblica Ceca 2
PT - Portogallo 2
SM - San Marino 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
LI - Liechtenstein 1
Totale 5.072
Salva come PNG Salva come JPEG
Città #
Chandler 629
Des Moines 339
Ashburn 309
Dublin 251
Fairfield 232
Jacksonville 189
New York 136
Boardman 110
Seattle 109
Wilmington 107
Woodbridge 91
Houston 83
Lawrence 83
Princeton 83
Cambridge 72
Ann Arbor 62
San Mateo 62
Centro 57
San Diego 40
Turin 39
Washington 38
Los Angeles 33
Pune 32
Boydton 28
London 23
Ancona 19
Tolentino 17
Brussels 15
Rome 15
Marche 14
Helsinki 11
Civitanova Marche 9
Menlo Park 9
Ascoli Piceno 8
Dronten 8
Kilburn 8
Norwalk 8
Falls Church 7
Pesaro 7
Cagliari 6
Moscow 6
Redmond 6
Redwood City 6
Bangkok 5
Beijing 5
Comunanza 5
Huskvarna 5
Iesi 5
New Bedfont 5
Prescot 5
Acton 4
Falconara Marittima 4
Frankfurt am Main 4
Gainesville 4
Guangzhou 4
Milan 4
Ottawa 4
Polverigi 4
Southwark 4
Abidjan 3
Arzano 3
Bari 3
Carini 3
Filottrano 3
Genoa 3
Guarulhos 3
Hangzhou 3
Hanover 3
Novara 3
Perugia 3
Shanghai 3
Toronto 3
Venegono Superiore 3
Vienna 3
Birmingham 2
Bolzano 2
Borgo Maggiore 2
Castello di Godego 2
Cingoli 2
Folignano 2
Lisbon 2
Meppel 2
Montréal 2
Piazzola sul Brenta 2
Porto 2
Porto San Giorgio 2
Reggio Calabria 2
San Benedetto del Tronto 2
St. Petersburg 2
Tokyo 2
Zacatecas City 2
Aberdeen 1
Acquaviva Picena 1
Adelaide 1
Alpharetta 1
Amendolara 1
Amsterdam 1
Andover 1
Aquila 1
Bellaria-Igea Marina 1
Totale 3.575
Salva come PNG Salva come JPEG
Nome #
null 193
Involvement of the oral cavity in psoriasis: results of a clinical study 110
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 97
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 88
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 82
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 81
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 80
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 78
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 77
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 76
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 74
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 74
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 70
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 70
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 69
Biologic Therapy in Psoriasis: Safety Profile 68
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 68
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 68
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 68
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 67
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 65
Oxidative stress and alterations of paraoxonases in atopic dermatitis 65
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 64
Mycosis Fungoides-like Eruption and Infliximab 64
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 64
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 63
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 62
Review: A safety profile of dalbavancin for onand off-label utilization 62
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 62
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 61
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 61
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 60
Relapsing acute generalized exanthematous pustolosis: a guess. 59
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 59
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 59
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 58
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 58
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 56
New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing. Antibiotics 56
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 54
Reticulated acanthoma with sebaceous differentiation 54
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 54
null 53
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 52
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 52
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 52
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance 52
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 52
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 52
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 51
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 50
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 50
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 50
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 50
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 50
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 50
null 50
New Skin Toxicities for New Anticancer Therapies 49
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 49
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. 48
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 47
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 47
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 47
null 47
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 46
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 45
Topical application of fumaric acid esters improves appearance of nail psoriasis 42
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 41
Phototherapy in Dermatology 41
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 39
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 37
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 37
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study. 37
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 34
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 34
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 33
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 32
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 32
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 31
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 31
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 30
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 30
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 30
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 29
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 29
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 27
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 26
null 22
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 22
Trichorhinophalangeal syndrome: a case report and brief literature review. 20
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 19
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease 19
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 19
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 19
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 18
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 17
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. 17
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 16
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 15
MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives 15
Totale 5.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 9 5
2019/2020318 22 0 24 15 60 4 44 17 48 6 23 55
2020/2021887 43 68 73 11 76 84 112 47 67 92 155 59
2021/2022693 16 100 27 12 29 46 25 53 47 28 137 173
2022/20231.943 133 190 123 179 114 503 8 107 386 10 130 60
2023/20241.146 162 25 151 136 166 296 27 71 19 92 1 0
Totale 5.304